Total Payments
$1,352
2024 Payments
$29.65
Companies
15
Transactions
74
Medicare Patients
320
Medicare Billing
$25,052
Payment Breakdown by Category
Food & Beverage$1,352 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,352 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $601.00 | 31 | $0 (2020) |
| Lilly USA, LLC | $214.11 | 12 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.51 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $98.64 | 7 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $76.70 | 5 | $0 (2021) |
| MannKind Corporation | $54.58 | 4 | $0 (2021) |
| Corcept Therapeutics | $36.38 | 3 | $0 (2020) |
| Genentech USA, Inc. | $29.65 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $27.21 | 2 | $0 (2020) |
| AbbVie Inc. | $24.86 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.65 | 1 | Genentech USA, Inc. ($29.65) |
| 2021 | $51.35 | 4 | Merck Sharp & Dohme Corporation ($13.93) |
| 2020 | $395.66 | 25 | Novo Nordisk Inc ($243.08) |
| 2019 | $672.55 | 38 | Lilly USA, LLC ($189.35) |
| 2018 | $135.60 | 2 | Novo Nordisk Inc ($135.60) |
| 2017 | $67.38 | 4 | Novo Nordisk Inc ($55.58) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/09/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Immunology | ||||||
| 07/13/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/28/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Diabetes | ||||||
| 01/21/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/08/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/25/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Endocrinology | ||||||
| 12/08/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.38 | General |
| 10/31/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Diabetes | ||||||
| 10/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Diabetes | ||||||
| 10/28/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Endocrinology | ||||||
| 10/20/2020 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
| 10/13/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.58 | General |
| 10/10/2020 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Endocrinology | ||||||
| 09/22/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.17 | General |
| 09/01/2020 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/27/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Endocrinology | ||||||
| 08/20/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.02 | General |
| 07/28/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Diabetes | ||||||
| 07/28/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: Diabetes | ||||||
| 07/23/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/06/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.40 | General |
| 06/08/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/12/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 05/11/2020 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: DIABETES | ||||||
| 05/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 33 | 33 | $2,970 | $422.24 |
| 2020 | 6 | 287 | 469 | $38,070 | $24,630 |
Total Patients
320
Total Services
502
Medicare Billing
$25,052
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 33 | $2,970 | $422.24 | 14.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 269 | $24,210 | $13,882 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 42 | 42 | $5,670 | $5,192 | 91.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 58 | 58 | $4,350 | $3,537 | 81.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 73 | 73 | $2,190 | $1,309 | 59.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 12 | 12 | $900.00 | $416.58 | 46.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 15 | 15 | $750.00 | $293.70 | 39.2% |
About Dr. Stephen Margolis, MD
Dr. Stephen Margolis, MD is a Internal Medicine healthcare provider based in Wyncote, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679523724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Margolis, MD has received a total of $1,352 in payments from pharmaceutical and medical device companies, with $29.65 received in 2024. These payments were reported across 74 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,352).
As a Medicare-enrolled provider, Margolis has provided services to 320 Medicare beneficiaries, totaling 502 services with total Medicare billing of $25,052. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Wyncote, PA
- Active Since 05/11/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679523724
Products in Payments
- Ozempic (Drug) $174.39
- Levemir (Drug) $122.33
- Saxenda (Drug) $119.90
- HUMULIN (Drug) $112.97
- OFEV (Drug) $102.39
- JANUVIA (Drug) $76.70
- Victoza (Drug) $70.35
- HUMULIN R 500 (Drug) $65.89
- TOUJEO (Drug) $58.03
- AFREZZA (Drug) $54.58
- Korlym (Drug) $36.38
- JARDIANCE (Drug) $32.61
- Ocrevus (Biological) $29.65
- FARXIGA (Drug) $27.21
- SOLIQUA 100/33 (Drug) $27.07
- SYNTHROID (Drug) $24.86
- GVOKE PFS (Drug) $14.48
- BD NANO (Device) $14.07
- SOLIQUA 100/33 (Biological) $13.54
- INVOKANA (Drug) $13.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyncote
Mary Schuler, Md, MD
Internal Medicine — Payments: $182.25
Internal Medicine $182.25
Aribelle Jones, M.d, M.D
Internal Medicine — Payments: $17.09
Internal Medicine $17.09
Dr. Alan Bilsky, Md, MD
Internal Medicine — Payments: $11.18
Internal Medicine $11.18
Dr. Melissa Schiffman, Md, MD
Internal Medicine
Internal Medicine
Dr. Donald Liss, Md, MD
Internal Medicine
Internal Medicine